SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 30.25-2.9%2:54 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bluegreen who wrote (13939)7/3/2000 5:58:27 PM
From: Cacaito  Read Replies (2) of 17367
 
And Blue, yes, lets take bpi out of the value (I have mentioned that 20 times), and maybe one will have a more fair share price to pay for it, cause there is LOTS of RISKs (proven failures all over the place) in the bpi line.

No value in the rest of the technology for many years or decades if at all.

And the only value is anticdlla and Yes there is heavy competition in the psoriasis AND the transplant field (anticd11a will be a late latecomer).

Baxter is not to be trusted, they were supposed to be the nice link to the FDA, results? REJECTION!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext